Loading the section…
The price of Standard BioTools Inc. (LAB) on October 9, 2026 is 0.6900 USD, +2.99% on the day. Over 52 weeks the stock traded between 0.6300 USD and 1.72 USD; the price now sits 6% of the way up that range. Over the past year the price changed by -47.73%. The P/E ratio is 3.4, which is below the sector median (25.0). Market capitalization is 269.20 million USD, rank 14 among 21 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −46.51 %
Standard BioTools Inc. trades on Nasdaq under the ticker LAB. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks LAB has traded between 0.6300 $ and 1.72 $. As of 9 October 2026 the price stood 5.50 % of the way from the 52-week low to the high.
Over one year LAB shares fell 47.73 %; over six months they fell 22.47 %. Volatility over 90 days is 89.89 %. Dividends are not included: this is price change only, as of 9 October 2026.
LAB trades at a price-to-earnings ratio of 3.4, below the sector median of 25.0. Price to sales is 4.1, above the sector median of 4.0. Price to book is 0.5, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 0.6800 | 0.7000 | 0.6600 | 0.6900 | 649,200 |
| 8 October 2026 | 0.6700 | 0.6800 | 0.6400 | 0.6700 | 2M |
| 7 October 2026 | 0.7100 | 0.7400 | 0.6800 | 0.6800 | 1M |
| 6 October 2026 | 0.7700 | 0.8000 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:50 MILK STREET 10TH FLOOR, BOSTON, MA, 02109, US
Standard BioTools Inc. reported revenue of 66M $ and net income of 78M $ over the last four quarters. Net margin is 119.07 %. Revenue changed by −23.86 % year over year. Earnings per share are 0.20 $. Market capitalisation is 269M $.
LAB has a return on equity of 13.94 %, above the sector median of −41.68 %. Return on assets is 12.24 %, above the sector median of −32.11 %. Operating margin is −136.68 %, below the sector median of −26.84 %.
| 305M |
| MTDMettler-Toledo International, Inc. | 1,549.99 | +1.34 % | 295M |
| TXG10x Genomics, Inc. | 80.65 | +4.36 % | 269M |
| BRKRBruker Corporation | 58.84 | +1.59 % | 135M |
| AVTRAvantor, Inc. | 15.67 | +1.82 % | 130M |
| 0.7200 |
| 0.7200 |
| 1M |
| 5 October 2026 | 0.7400 | 0.8000 | 0.7400 | 0.7600 | 1M |
| 2 October 2026 | 0.7300 | 0.7600 | 0.7300 | 0.7400 | 786,500 |
| 1 October 2026 | 0.7400 | 0.7500 | 0.7200 | 0.7300 | 1M |
| 30 September 2026 | 0.7200 | 0.7400 | 0.7100 | 0.7400 | 2M |
| 29 September 2026 | 0.7300 | 0.7300 | 0.7100 | 0.7100 | 173,400 |
| 28 September 2026 | 0.7500 | 0.7500 | 0.7200 | 0.7300 | 479,000 |
| 25 September 2026 | 0.7400 | 0.7500 | 0.7100 | 0.7400 | 471,800 |
| 24 September 2026 | 0.7400 | 0.7700 | 0.7400 | 0.7400 | 743,900 |
| 23 September 2026 | 0.7500 | 0.7700 | 0.7300 | 0.7400 | 653,400 |
| 22 September 2026 | 0.7400 | 0.7700 | 0.7400 | 0.7500 | 1M |
| 21 September 2026 | 0.7600 | 0.7600 | 0.7300 | 0.7400 | 459,600 |
| 18 September 2026 | 0.7200 | 0.7700 | 0.7000 | 0.7700 | 3M |
| 17 September 2026 | 0.7200 | 0.7500 | 0.7200 | 0.7300 | 664,900 |
| 16 September 2026 | 0.6900 | 0.7400 | 0.6900 | 0.7100 | 982,300 |
| 15 September 2026 | 0.6800 | 0.7000 | 0.6800 | 0.6900 | 841,700 |
| 14 September 2026 | 0.6900 | 0.7100 | 0.6800 | 0.7000 | 695,600 |